LND-101001

N/A

Report date: 2023/01/01 08:31:19
NME

Base Information

Drug NameLND-101001
Drug Alias NameLND-101001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor protein alpha-7 subunit modulators
TargetsNeuronal acetylcholine receptor protein alpha-7 subunit
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLupin Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLupin Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A